Dmedici Ltd 08690865 false 2024-10-01 2025-09-30 2025-09-30 The principal activity of the company is providing medical services Digita Accounts Production Advanced 6.30.9574.0 true 08690865 2024-10-01 2025-09-30 08690865 2025-09-30 08690865 core:CurrentFinancialInstruments 2025-09-30 08690865 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 08690865 core:FurnitureFittingsToolsEquipment 2025-09-30 08690865 bus:SmallEntities 2024-10-01 2025-09-30 08690865 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 08690865 bus:FilletedAccounts 2024-10-01 2025-09-30 08690865 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 08690865 bus:RegisteredOffice 2024-10-01 2025-09-30 08690865 bus:CompanySecretaryDirector1 2024-10-01 2025-09-30 08690865 bus:OrdinaryShareClass1 2024-10-01 2025-09-30 08690865 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 08690865 bus:Agent1 2024-10-01 2025-09-30 08690865 core:FurnitureFittings 2024-10-01 2025-09-30 08690865 core:FurnitureFittingsToolsEquipment 2024-10-01 2025-09-30 08690865 countries:England 2024-10-01 2025-09-30 08690865 2024-09-30 08690865 core:FurnitureFittingsToolsEquipment 2024-09-30 08690865 2023-10-01 2024-09-30 08690865 2024-09-30 08690865 core:CurrentFinancialInstruments 2024-09-30 08690865 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 08690865 core:FurnitureFittingsToolsEquipment 2024-09-30 08690865 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 iso4217:GBP xbrli:pure

Registration number: 08690865

Dmedici Ltd
trading as Dmedici ltd
Unaudited Filleted Abridged Financial Statements
for the Year Ended 30 September 2025

Dmedici Ltd
trading as Dmedici ltd

Contents

Company Information | 1
Abridged Balance Sheet | 2 to 3
Notes to the Unaudited Abridged Financial Statements | 4 to 7

Dmedici Ltd
trading as Dmedici ltd

Company Information

Director | Dr Amar Deep Singh Mann

Company secretary | Dr Amar Deep Singh Mann

Registered office | Middlesex House 130 College Road Harrow Middlesex HA1 1BQ

Accountants | Charles Rippin & Turner Chartered AccountantsMiddlesex House 130 College Road Harrow Middlesex HA1 1BQ

Dmedici Ltd
trading as Dmedici ltd

(Registration number: 08690865)
Abridged Balance Sheet as at 30 September 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 1,758 | 2,436
Current assets |  |  |
Debtors |  | 36,242 | 36,242
Cash at bank and in hand |  | 25,052 | 17,382
|  | 61,294 | 53,624
Creditors: Amounts falling due within one year |  | (51,634) | (50,229)
Net current assets |  | 9,660 | 3,395
Total assets less current liabilities |  | 11,418 | 5,831
Accruals and deferred income |  | (2,315) | (2,200)
Net assets |  | 9,103 | 3,631
Capital and reserves |  |  |
Called up share capital | 5 | 3 | 3
Retained earnings |  | 9,100 | 3,628
Shareholders' funds |  | 9,103 | 3,631

For the financial year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 3 December 2025

Dmedici Ltd
trading as Dmedici ltd

(Registration number: 08690865)
Abridged Balance Sheet as at 30 September 2025

......................................... Dr Amar Deep Singh Mann Company secretary and director

Dmedici Ltd
trading as Dmedici ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2025

1 | General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

These financial statements were authorised for issue by the director on 3 December 2025.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Dmedici Ltd
trading as Dmedici ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2025

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Fixtures and fittings | 20% Reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Dmedici Ltd
trading as Dmedici ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2025

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

Dmedici Ltd
trading as Dmedici ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2025

4 | Tangible assets

| Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 October 2024 | 17,655 | 17,655
At 30 September 2025 | 17,655 | 17,655
Depreciation
At 1 October 2024 | 15,219 | 15,219
Charge for the year | 678 | 678
At 30 September 2025 | 15,897 | 15,897
Carrying amount
At 30 September 2025 | 1,758 | 1,758
At 30 September 2024 | 2,436 | 2,436

5 | Share capital

6 | Dividends

Interim dividends paid

|  | 2025 £ |  | 2024 £
Interim dividend of £16,667.00 per each Ordinary shares |  | 50,000 |  | 50,000